Nathan Stasko News Today

/PRNewswire/ -- Vast Therapeutics announces publication of a manuscript in the journal of Antimicrobial Agents & Chemotherapy describing the utility of its...

StockNews.com upgraded shares of Novan (NASDAQ:NOVN – Get Rating) from a sell rating to a hold rating in a research report sent to investors on Friday. Separately, Cantor Fitzgerald reiterated an overweight rating and issued a $8.00 target price on shares of Novan in a research note on Friday. Novan Stock Performance Shares of NASDAQ:NOVN […]

StockNews.com upgraded shares of Novan (NASDAQ:NOVN – Get Rating) from a sell rating to a hold rating in a research report sent to investors on Friday. Separately, Cantor Fitzgerald reissued an overweight rating and issued a $8.00 price objective on shares of Novan in a research report on Friday. Novan Stock Up 8.3 % Shares […]

Novan (NASDAQ:NOVN – Get Rating) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Friday. Separately, Cantor Fitzgerald restated an “overweight” rating and issued a $8.00 price target on shares of Novan in a report on Friday. Novan Price Performance NASDAQ NOVN traded […]

Wall Street brokerages forecast that Novan, Inc. (NASDAQ:NOVN – Get Rating) will post ($0.55) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Novan’s earnings. The lowest EPS estimate is ($0.73) and the highest is ($0.46). Novan reported earnings per share of ($0.60) in the […]

Novan (NASDAQ:NOVN – Get Rating)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a note issued to investors on Tuesday, TipRanks reports. They currently have a $24.00 target price on the stock. NOVN traded up $0.08 during trading on Tuesday, reaching $3.33. 500 shares of the company’s stock were exchanged, […]